Lipoflex Plus (Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin)

The amino‑acid blend supplies the building blocks required for protein synthesis directly into the bloodstream. By delivering essential amino acids, it stimulates the mTOR signaling pathway, promotes tissue repair, and helps restore nitrogen balance, which is crucial for patients with increased catabolic stress or limited enteral intake.

The dose of Lipoflex Plus is individualized by the prescribing clinician based on the patient’s weight, clinical condition, renal and hepatic function, and overall nutritional goals. Healthcare professionals calculate the appropriate infusion rate and total daily amount to meet the patient’s specific amino‑acid requirements.

Safety data for Lipoflex Plus in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. The prescribing clinician must evaluate the clinical situation and discuss any concerns with the patient.

To order Lipoflex Plus, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and the necessary import documentation.

Lipoflex Plus offers a comprehensive profile of ten amino acids, including both essential and conditionally essential ones, in a single sterile solution. Compared with products that contain a narrower amino‑acid spectrum, Lipoflex Plus may provide more balanced nutrition, potentially reducing the need for additional supplementation, while still requiring individualized dosing based on patient needs.

Lipoflex Plus must be stored at 2‑8 °C, protected from light, and kept in its original container. It should not be frozen or shaken vigorously. Before administration, inspect the solution for particulate matter or discoloration and allow it to reach room temperature if required by the infusion protocol.

Lipoflex Plus is administered intravenously as a sterile solution. The infusion is typically given through a dedicated IV line using an infusion pump or controlled drip, with the rate determined by the prescribing clinician based on the patient’s nutritional plan and clinical status.

The most serious risks include severe hypersensitivity reactions such as anaphylaxis, significant electrolyte disturbances (e.g., hyperkalemia, hypocalcemia), metabolic acidosis, and acute renal dysfunction. Prompt recognition and management of these events are essential, and patients should be monitored closely during and after infusion.

Lipoflex Plus should be avoided in patients with known hypersensitivity to any of its amino‑acid components, those with uncontrolled severe electrolyte imbalances, or individuals with acute renal failure where amino‑acid load cannot be safely managed. Clinical judgment is required for each case.